Press Releases BioVaxys Technology Corp.

Equities

BIOV

CA09076M1014

Delayed Canadian Securities Exchange Other stock markets 03:35:54 2024-05-15 pm EDT			5-day change	1st Jan Change
0.07 ^CAD	-12.50%		-.--%	+40.00%

May. 02	Biovaxys Technology Corp. Delays to File Its Interim Financial Statements for the Three Months Ended January 31, 2024	CI
Apr. 30	BioVaxys Technology Corp. Appoints Christopher Cherry as Chief Financial Officer	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

BioVaxys Technology Corp. Announces Failure to File Cease Trade Order	May. 16	AQ
CSE Bulletin: Suspension - BioVaxys Technology Corp. (BIOV)	May. 16	NE
Canadian Investment Regulatory Organization Trading Halt - BIOV	May. 16	AQ
BioVaxys Technology Corp. Closes SECOND Tranche of Private Placement	May. 10	AQ
BioVaxys Technology Corp. Closes First Tranche of Private Placement	May. 03	AQ
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update	May. 02	AQ
Biotech Innovations Aim to Combat Soaring Cancer Diagnoses by 2050	May. 01	AQ
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update	Apr. 18	AQ
BIOVAXYS AND SPAYVAC-FOR-WILDLIFE, INC. ANNOUNCE LAUNCH OF FIELD TRIAL FOR LARGE-SCALE IMMUNOCONTRACEPTION IN THE COMMERCIAL AQUATIC FARMING INDUSTRY	Apr. 10	AQ
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update	Apr. 04	AQ
BIOVAXYS ANNOUNCES PLANNED PRIVATE PLACEMENT	Mar. 22	AQ
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update	Mar. 21	AQ
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update	Mar. 07	AQ
Annual Financial Statements Update for the Year Ended October 31, 2023	Feb. 21	AQ
BIOVAXYS COMPLETES THE ACQUISITION OF ALL INTELLECTUAL PROPERTY, IMMUNOTHERAPEUTICS PLATFORM TECHNOLOGY, AND CLINICAL STAGE ASSETS OF THE FORMER IMV INC.	Feb. 21	AQ
Canadian Investment Regulatory Organization Trade Resumption - BIOV	Feb. 12	AQ
BioVaxys Acquires All Intellectual Property, Immunotherapeutics Platform Technology, and Clinical Stage Assets of the Former IMV Inc.	Feb. 12	AQ
Canadian Investment Regulatory Organization Trading Halt - BIOV	Feb. 12	AQ
BIOVAXYS ANNOUNCES COMPLETION OF FIRST TRANCHE OF PRIVATE PLACEMENT	Feb. 01	AQ
BioVaxys Executes Letter of Intent for Major Immunotherapeutics Technology Acquisition	Dec. 22	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases BioVaxys Technology Corp.

Equities

BIOV

CA09076M1014

Press Releases

Filters